AI-powered MRI radiomics significantly improves prediction of treatment response in advanced liver cancer patients.
Key Details
- 1Multicenter study presented at ASCO 2025 focused on advanced hepatocellular carcinoma (HCC).
- 2AI-based radiomics model analyzed MRI data to predict response to atezolizumab and bevacizumab therapy.
- 3Study included 240 patients; training cohort of 161, validation cohort of 79.
- 4Radiomics model achieved AUC of 0.913 (training) and 0.825 (validation); combined with a key MRI feature, AUC increased to 0.951 and 0.835, respectively.
- 5Significant correlation found between radiomic and conventional MRI features for intrahepatic lesions.
Why It Matters
This work demonstrates the power of AI-driven radiomics to personalize cancer treatment planning, improve patient selection for liver cancer therapies, and highlights growing integration of advanced imaging analytics in clinical oncology workflows.
Source
AuntMinnie
Related News
•AuntMinnie
Radiology Receives Declining Share of Industry Research Funding
Radiologists received only 1.1% of industry-funded research payments in 2024, with a continuing downward trend.
•AuntMinnie
GPT-4o AI Matches Radiologists in Follow-Up Imaging Recommendations
GPT-4o matched the performance of experienced radiologists and surpassed residents in recommending follow-up imaging from routine radiology reports.
•Cardiovascular Business
AI Leverages Head CTs for Automated Heart Risk Assessments
AI models can turn routine head CT scans into automated cardiovascular risk assessments, expanding the utility of radiology studies.